T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients

Article ID	Journal	Published Year	Pages	File Type
8739674	Journal of Clinical Virology	2018	23 Pages	PDF

Abstract

The QuantiFERON-CMV and T-Track-CMV enable the functional assessment of CMV-specific CMI in KTx recipients. In combination with CMV viral load monitoring, T-Track-CMV results could stratify patients at risk of CMV reactivation/infection.

Keywords

VGCV ELISPOT PBMCs CNI CMI MMF ATG anti-thymocyte globulin GCV Valganciclovir mTOR KTx ROC SFU AUC human leukocyte antigens HLA SOT standard deviation Donor Cell-mediated immunity recipient peripheral blood mononuclear cells cytomegalovirus CMV confidence interval Month mycophenolate mofetil receiver operating curve area under curve calcineurin inhibitor mammalian target of rapamycin week Transplantation Solid-organ transplant Kidney transplant Quantiferon Ganciclovir

Related Topics

Life Sciences Immunology and Microbiology Applied Microbiology and Biotechnology

Preview

T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients

Authors

Smaranda Gliga, Johannes Korth, Adalbert Krawczyk, Benjamin Wilde, Peter A. Horn, Oliver Witzke, Monika Lindemann, Melanie Fiedler,